太龙药业：明日开市起继续停牌

Core Viewpoint - Tailong Pharmaceutical (600222.SH) announced that its controlling shareholder, Tai Rong Chan Investment, is planning a share transfer that may lead to a change in the company's control [1] Group 1: Share Transfer and Control Change - The controlling shareholder is actively promoting the major share transfer matter and negotiating transaction terms with the counterparties [1] - The company has applied to the Shanghai Stock Exchange for a continued trading suspension, which is expected to last no more than three trading days [1] - The stock will remain suspended from trading starting December 4, 2025, as the company cannot resume trading on that date [1]